Redox is a technology company.
Redox has raised $92.5M across 6 funding rounds.
Key people at Redox.
Redox has raised $92.5M in total across 6 funding rounds.
Key people at Redox.
Redox has raised $92.5M in total across 6 funding rounds.
Redox's investors include Battery Ventures, Headwater Ventures, RRE Ventures, Duncan Gills, Flybridge, Shivon Zilis, HealthX Ventures.
Redox refers to multiple entities, but the most prominent technology company matching this description is Redox (redoxengine.com), a health tech firm building a unified platform for healthcare data exchange. It serves providers, payers, health tech vendors, electronic health record (EHR) systems, and life sciences companies by solving interoperability challenges—enabling quick, secure data sharing to improve patient care, workflows, and billing.[3] Unlike environmental remediation firms like Redox Tech (founded 1995, specializing in in situ soil/groundwater treatment with $5.8M revenue)[2][5] or consulting firms like Redox Technologies Inc. (focused on advanced oxidation tech since 2000),[1] this Redox powers the healthcare ecosystem with its API-based network, driving growth amid rising digital health demands.[3]
Redox emerged to tackle fragmented healthcare data systems, though specific founder details are not detailed in available sources. The company developed its platform and expansive connection network to bridge providers, payers, EHRs, and vendors, streamlining exchanges that were previously slow and insecure.[3] Early traction likely stemmed from the need for effective patient treatment, workflow optimization, and faster payments, positioning it as a key enabler in health tech integration.
Redox rides the healthcare interoperability wave, fueled by regulations like FHIR standards and the push for digital health post-pandemic. Timing is ideal amid exploding health tech adoption, with market forces like AI-driven analytics and value-based care demanding seamless data—Redox's network amplifies this by reducing integration friction.[3] It influences the ecosystem by empowering startups and incumbents to innovate faster, fostering a more connected landscape where data silos hinder progress.
Redox is poised to expand as AI and personalized medicine amplify data needs, potentially deepening integrations with emerging telehealth and genomics players. Trends like regulatory mandates for interoperability and payer-provider consolidation will propel growth, evolving its role from connector to indispensable orchestrator. This positions Redox as a cornerstone in health tech's data revolution, building on its mission to unlock possibilities through streamlined exchange.[3]
Redox has raised $92.5M across 6 funding rounds. Most recently, it raised $45.0M Series D in February 2021.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Feb 1, 2021 | $45.0M Series D | Battery Ventures, Headwater Ventures, RRE Ventures, Duncan Gills | |
| Apr 1, 2019 | $33.0M Series C | Battery Ventures, Headwater Ventures, RRE Ventures, Duncan Gills | |
| Apr 1, 2017 | $1.0M Series B | Flybridge, Headwater Ventures, RRE Ventures, Shivon Zilis | |
| Jan 1, 2017 | $9.0M Series B | Flybridge, Headwater Ventures, RRE Ventures, Shivon Zilis | |
| Oct 1, 2015 | $4.0M Series A | Flybridge, Shivon Zilis | |
| Nov 1, 2014 | $470K Seed | HealthX Ventures |
